Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pearson

This article was originally published in The Tan Sheet

Executive Summary

Justice Department, Emord & Associates jointly move June 1 to dismiss folic acid/NTD supplement health claim litigation based on agency's allowance of claim when accompanied by disclaimer. Pearson plaintiffs also will file suit within next 60 days challenging FDA's decision to deny antioxidant vitamin/cancer claim. Complaint will target FDA's failure to evaluate disclaimer language. In its review, FDA cited studies suggesting antioxidants may have negative effect on cancer (1"The Tan Sheet" May 14, p. 10). Emord also will seek to extend Pearson to foods with new petition for low-fat pancake mix making omega-3, omega-6 fatty acids/reduced CHD risk claim; firm will file within 90 days
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS092658

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel